highly significantP = 0.001
Using the log-rank test, we observed a highly significant survival rate in the low rSec62 group compared with the high rSec62 group among all lung cancer patients, and SCC patients ( P = 0.001 for all NSCLC patients, P = 0.001 for SCC patients, P = 0.054 for AC patients).